Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge

BACKGROUND: Ebola virus (EBOV), variant Makona, was the causative agent of the 2013–2016 West African epidemic responsible for almost 30,000 human infections and over 11,000 fatalities. During the epidemic, the development of several experimental vaccines was accelerated through human clinical trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Marzi, Andrea, Reynolds, Pierce, Mercado-Hernandez, Reinaldo, Callison, Julie, Feldmann, Friederike, Rosenke, Rebecca, Thomas, Tina, Scott, Dana P., Hanley, Patrick W., Haddock, Elaine, Feldmann, Heinz
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Research paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945200/
https://ncbi.nlm.nih.gov/pubmed/31631035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.09.055
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados